Siwang Yu

6.1k total citations · 2 hit papers
90 papers, 5.0k citations indexed

About

Siwang Yu is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Siwang Yu has authored 90 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 16 papers in Pharmacology and 9 papers in Organic Chemistry. Recurrent topics in Siwang Yu's work include Genomics, phytochemicals, and oxidative stress (33 papers), Pharmacological Effects of Natural Compounds (14 papers) and Glutathione Transferases and Polymorphisms (12 papers). Siwang Yu is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (33 papers), Pharmacological Effects of Natural Compounds (14 papers) and Glutathione Transferases and Polymorphisms (12 papers). Siwang Yu collaborates with scholars based in China, United States and Thailand. Siwang Yu's co-authors include Ah‐Ng Tony Kong, Tin Oo Khor, Wenge Li, Guoxiang Shen, Changjiang Xu, Jung Hwan Kim, Woo‐Sik Jeong, Xiaoling Yuan, Angela Kong and Xue Qiao and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Siwang Yu

89 papers receiving 5.0k citations

Hit Papers

Activation of Nrf2-antioxidant signaling attenuates NFκB-... 2008 2026 2014 2020 2008 2022 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siwang Yu China 36 3.4k 558 509 431 428 90 5.0k
Hua Yang China 39 2.4k 0.7× 559 1.0× 466 0.9× 369 0.9× 550 1.3× 227 5.0k
Xiu Jun Wang China 28 3.1k 0.9× 416 0.7× 464 0.9× 236 0.5× 291 0.7× 80 4.6k
Bonglee Kim South Korea 39 2.5k 0.7× 480 0.9× 409 0.8× 545 1.3× 624 1.5× 283 5.3k
Hye‐Kyung Na South Korea 43 3.4k 1.0× 472 0.8× 351 0.7× 699 1.6× 485 1.1× 106 5.9k
Tin Oo Khor United States 44 4.9k 1.4× 494 0.9× 629 1.2× 409 0.9× 583 1.4× 72 6.7k
Tadashi Honda United States 43 4.5k 1.3× 456 0.8× 849 1.7× 425 1.0× 364 0.9× 123 6.0k
Joydeb Kumar Kundu South Korea 43 3.0k 0.9× 886 1.6× 371 0.7× 546 1.3× 603 1.4× 83 5.8k
Tae Cheon Jeong South Korea 36 2.2k 0.6× 811 1.5× 779 1.5× 590 1.4× 465 1.1× 181 4.5k
Bao Ting Zhu United States 38 2.6k 0.8× 850 1.5× 339 0.7× 469 1.1× 426 1.0× 160 6.6k
Guoxiang Shen United States 29 3.1k 0.9× 304 0.5× 492 1.0× 211 0.5× 438 1.0× 40 4.2k

Countries citing papers authored by Siwang Yu

Since Specialization
Citations

This map shows the geographic impact of Siwang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siwang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siwang Yu more than expected).

Fields of papers citing papers by Siwang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siwang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siwang Yu. The network helps show where Siwang Yu may publish in the future.

Co-authorship network of co-authors of Siwang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Siwang Yu. A scholar is included among the top collaborators of Siwang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siwang Yu. Siwang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jingya, et al.. (2021). The potential roles of Nrf2/Keap1 signaling in anticancer drug interactions. SHILAP Revista de lepidopterología. 2. 100028–100028. 11 indexed citations
2.
Liu, Jiarui, et al.. (2018). The Leptin Resistance. Advances in experimental medicine and biology. 1090. 145–163. 66 indexed citations
4.
Ren, Yonggang, Lu Qiu, Feng-Lin Lu, et al.. (2016). TALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cells. Scientific Reports. 6(1). 23775–23775. 35 indexed citations
5.
He, Liu, et al.. (2016). Activation of Nrf2-ARE signaling mitigates cyclophosphamide-induced myelosuppression. Toxicology Letters. 262. 17–26. 13 indexed citations
6.
Yu, Siwang, Chung S. Yang, Junyao Li, et al.. (2015). Cancer Prevention Research in China. Cancer Prevention Research. 8(8). 662–674. 25 indexed citations
7.
Jin, Feng, Wenfei Liang, Shuai Ji, et al.. (2015). Microbial transformation of isoangustone A by Mucor hiemalis CGMCC 3.14114. Journal of Chinese Pharmaceutical Sciences. 24(5). 285. 1 indexed citations
8.
Su, Zheng‐Yuan, Limin Shu, Jong Hun Lee, et al.. (2013). 食用植物成分和中药用于癌症化学预防:Nrf2,表观基因组学,癌症干细胞. Huaxue jinzhan. 25(9). 1526–1543. 3 indexed citations
9.
Wu, Tien‐Yuan, Tin Oo Khor, Zheng‐Yuan Su, et al.. (2013). Epigenetic Modifications of Nrf2 by 3,3′-diindolylmethane In Vitro in TRAMP C1 Cell Line and In Vivo TRAMP Prostate Tumors. The AAPS Journal. 15(3). 864–874. 74 indexed citations
10.
Cao, Baoshan, et al.. (2012). Association analysis of the expression level of Nrf2 mRNA in peripheral blood nucleated cells and the severity of chemotherapy-induced myelosuppression. Tumori. 32(2). 124–129. 2 indexed citations
11.
Liang, Yonghong, Wei Wang, Siwang Yu, et al.. (2010). A new chiratane type triterpenoid from the rhizomes of Drynaria fortunei. Fitoterapia. 81(8). 988–991. 14 indexed citations
12.
Khor, Tin Oo, Mou‐Tuan Huang, Auemduan Prawan, et al.. (2008). Increased Susceptibility of Nrf2 Knockout Mice to Colitis-Associated Colorectal Cancer. Cancer Prevention Research. 1(3). 187–191. 256 indexed citations
13.
Khor, Tin Oo, et al.. (2008). Chemoprevention of prostate cancer in TRAMP mice by Dibenzoylmethane (DBM). Cancer Research. 68. 3053–3053.
14.
Barve, Avantika, Tin Oo Khor, Sujit Nair, et al.. (2008). Pharmacokinetics, Pharmacodynamics and Drug Metabolism. Journal of Pharmaceutical Sciences. 97(10). 4528–4545. 32 indexed citations
15.
Shen, Guoxiang, Tin Oo Khor, Rong Hu, et al.. (2007). Chemoprevention of Familial Adenomatous Polyposis by Natural Dietary Compounds Sulforaphane and Dibenzoylmethane Alone and in Combination in Apc Min/+ Mouse. Cancer Research. 67(20). 9937–9944. 119 indexed citations
16.
Yu, Siwang & Ah‐Ng Tony Kong. (2007). Targeting Carcinogen Metabolism by Dietary Cancer Preventive Compounds. Current Cancer Drug Targets. 7(5). 416–424. 39 indexed citations
17.
Lin, Wen, Guoxiang Shen, Xiaoling Yuan, et al.. (2006). Regulation of Nrf2 Transactivation Domain Activity by p160 RAC3/SRC3 and Other Nuclear Co-Regulators. BMB Reports. 39(3). 304–310. 33 indexed citations
18.
Li, Wenge, Siwang Yu, & Angela Kong. (2006). Nrf2 Possesses a Redox-sensitive Nuclear Exporting Signal in the Neh5 Transactivation Domain. Journal of Biological Chemistry. 281(37). 27251–27263. 131 indexed citations
19.
Cong, Cong, Hu, Qiong, et al.. (2005). A Novel Protein Found in Selenium-rich Silkworm Pupas. 中国化学快报:英文版. 16(10). 1347–1350. 2 indexed citations
20.
Yu, Siwang, Lan Yuan, Xiaoda Yang, et al.. (2004). La3+‐promoted proliferation is interconnected with apoptosis in NIH 3T3 cells. Journal of Cellular Biochemistry. 94(3). 508–519. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026